Cullinan Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 79K | 0 | 0 | 0 | 0 | 0 | 0 | 77K |
| Gross Profit | -79K | 0 | 0 | 0 | 0 | 0 | 0 | -77K |
| R&D Expenses | 42.1M | 42.9M | 42.0M | 61.0M | 41.5M | 40.5M | 35.5M | 36.3M |
| Operating Expenses | 53.7M | 55.3M | 55.6M | 75.8M | 55.0M | 55.0M | 48.9M | 50.0M |
| Operating Income | -53.7M | -55.3M | -55.6M | -75.8M | -55.0M | -55.0M | -48.9M | -50.0M |
| Other Income / Gains | 4.0M | 4.5M | 5.0M | 5.7M | 6.5M | 7.5M | 8.3M | 8.0M |
| Net Income | -49.7M | -50.7M | -50.6M | -70.1M | -48.5M | -47.6M | -40.6M | -42.0M |
| EPS (Diluted) | -0.84 | -0.86 | -0.86 | -1.19 | -0.82 | -0.81 | -0.70 | -0.76 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 11.6M | 12.3M | 13.6M | 14.8M | 13.5M | 14.6M | 13.3M | 13.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -77K |
| Selling General And Administrative Expenses | 11.6M | 12.3M | 13.6M | 14.8M | 13.5M | 14.6M | 13.3M | 13.7M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 53.7M | 55.3M | 55.6M | 75.8M | 55.0M | 55.0M | 48.9M | 50.0M |
| Interest Income | 4.1M | 4.6M | 5.1M | 5.9M | 6.6M | 7.5M | 8.4M | 8.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 79K | 79K | 79K | 77K | 76K | 77K | 76K | 77K |
| Ebitda | -49.6M | -50.6M | -50.5M | -70.0M | -48.4M | -47.5M | -40.5M | -42.0M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -49.7M | -50.7M | -50.6M | -70.1M | -48.5M | -47.5M | -40.6M | -42.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 117K | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.84 | -0.86 | -0.86 | -1.19 | -0.82 | -0.81 | -0.70 | -0.76 |
| Weighted Average Shs Out | 59.2M | 59.2M | 59.0M | 59.0M | 58.9M | 58.6M | 58.3M | 55.1M |
| Weighted Average Shs Out Dil | 59.2M | 59.2M | 59.0M | 59.0M | 58.9M | 58.6M | 58.3M | 55.1M |